Dr Glenn Warner, a renowned oncologist who passed away in 2000, said that the multi-billion dollar cancer industry in the United States “is killing people, right and left, just for financial gain” while Dr Charles Mathe, French cancer specialist, said he would never go to a standard cancer treatment centre if he contracted cancer.
Most chemotherapy patients either pass away or are plagued with illness within ten to 15 years after treatment and, according to The Mind Unleashed, they live in a permanent state of disease until their death. Doctors usually tell their patients the survival rate is five years, after which the mortality rate increases dramatically. Still, according to a 12-year meta-analysis published in the Journal of Clinical Oncology, 97 per cent of the time adults receive chemotherapy this treatment does not help regress the metastatic cancers. Despite this shocking percentage, Dr Peter Glidden explained that chemotherapy remains one of the main treatments in the battle against cancer.
Cancer treatment is a US$100 billion business and, even though new treatments appear every day, this disease has become more virulent than ever. For example, in 2011, cancer was the number one cause of death in the Western world and the second cause of death in developing countries. According to Dr Glidden, the easiest way to explain this situation is by looking at the financial gains. When doctors tell patients they have to start chemotherapy, they buy it from pharmaceutical companies for about US$5,000 sell it to the patients for over US$10,000, insurance pays its part and they end up pocketing the difference. This could explain why people are aware that alcohol and tobacco may lead to cancer, but they don’t know that cancer treatment is another cause of secondary cancers.
A group of scientists wrote in Nature Medicine that, after testing the effects of a type of chemotherapy on tissue from men with prostate cancer, they found “evidence of DNA damage” in healthy cells after cancer treatment. Tumours initially respond well, but they regrow and develop resistance to further chemotherapy. The team of researchers confirmed that “damage responses in benign cells […] may directly contribute to enhanced tumour growth kinetics.” Plus, doctors know they should not offer cancer treatment to terminally-ill patients, because it often does more harm than good. Dr John Diamond, M.D, cited a study of over 10,000 patients, which found that people who underwent chemotherapy were 14 times more likely to develop leukaemia and six times more likely to develop other types of cancers than those who did not undergo chemotherapy.
Still, this treatment continues to be sought-after.